Institutional Ownership Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE). We have compiled data on the 144 institutions that hold shares in the stock, with a total of 96 Million shares, which have been reported (via 13F filing form) to have a value of $96.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Redmile Group, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
12,872,946
shares
|
$15.7 Million
1.07% of portfolio
|
Q4 2024
Reduced 2.25%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
10,310,453
shares
|
$12.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.22%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,116,106
shares
|
$12.3 Million
0.0% of portfolio
|
Q2 2024
Added 11.17%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
7,794,513
shares
|
$9.51 Million
0.04% of portfolio
|
Q1 2025
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
4,289,159
shares
|
$5.23 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.12%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
3,398,283
shares
|
$4.15 Million
0.0% of portfolio
|
Q1 2025
Added 103.54%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
May 07, 2025 Q1 2025 |
3,379,064
shares
|
$4.12 Million
0.89% of portfolio
|
Q3 2021
New holding
|
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
3,258,402
shares
|
$3.98 Million
0.03% of portfolio
|
Q4 2024
Added 8.69%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
2,591,558
shares
|
$3.16 Million
0.0% of portfolio
|
Q1 2025
Reduced 10.59%
|
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,515,850
shares
|
$3.07 Million
0.14% of portfolio
|
Q1 2025
Added 2.06%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
2,458,974
shares
|
$3 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.7%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,269,609
shares
|
$2.77 Million
0.0% of portfolio
|
Q1 2025
Added 1.91%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,240,058
shares
|
$2.73 Million
0.0% of portfolio
|
Q1 2025
Reduced 20.63%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
2,203,323
shares
|
$2.69 Million
0.01% of portfolio
|
Q1 2025
Added 38.84%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,110,065
shares
|
$2.57 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.26%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
1,937,133
shares
|
$2.36 Million
0.0% of portfolio
|
Q1 2025
Added 147.75%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,867,773
shares
|
$2.28 Million
0.1% of portfolio
|
Q1 2025
Added 0.64%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,680,580
shares
|
$2.05 Million
0.04% of portfolio
|
Q3 2024
Added 24.0%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
1,551,081
shares
|
$1.89 Million
0.0% of portfolio
|
Q1 2025
Added 40.57%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,473,792
shares
|
$1.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 8.01%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,424,167
shares
|
$1.74 Million
0.01% of portfolio
|
Q1 2025
Added 0.1%
|
|
|
Monaco Asset Management Sam
|
May 08, 2025 Q1 2025 |
1,149,708
shares
|
$1.4 Million
0.19% of portfolio
|
Q1 2025
Added 250.87%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,090,260
shares
|
$1.33 Million
0.01% of portfolio
|
Q2 2023
Reduced 9.09%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
794,973
shares
|
$969,867
0.0% of portfolio
|
Q1 2025
Reduced 1.31%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
787,000
shares
|
$960,140
0.0% of portfolio
|
Q1 2025
Reduced 4.96%
|